EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program
EXCLUSIVE: Cybin Tells Benzinga 'The Company Is Evaluating Non-hallucinogenic Dosing of CYB005 Preclinical Candidate Molecules for the Treatment of CNS Disorders'
EXCLUSIVE: Cybin Tells Benzinga Co. Announces Grant Of First U.S Composition of Matter Patent N Support Of Its CYB005 Phenethylamines Program
FDA Is Said to See "Path Forward" for Ecstasy-based Drug
Bright Minds Rally Ends as Psychedelic Stocks Extend Volatility
Cybin Inc. CEO to Speak at Research Event
Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024
Cybin Gears Up for Global Phase 3 Depression Trial
Water Tower Research Publishes Initiation of Coverage Report on Cybin, Inc., "A Leader in Novel Neuropsychiatry Therapeutics"
Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
Strong Buy Rating for Cybin Inc. on Promising Clinical Advances and Strategic Management Positioning
Cybin Is Maintained at Buy by Canaccord Genuity
Express News | Cybin Inc : Canaccord Genuity Cuts Target Price to $96 From $114
Cybin Provides Corporate Update On Upcoming Clinical Milestones; Initiation Of Pivotal CYB003 Phase 3 Study In Major Depressive Disorder Expected Imminently; 12-Month Efficacy Data From Phase 2 Study Of CYB003 In MDD Expected In Early Q4 2024; Phase 2...
Catalyst Watch: FOMC, FedEx Earnings, Electronic Arts Event, and Triple Witching Day
Leadership Shake-Ups In Cannabis And Psychedelics: Maryland's Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More
Cybin To Carry Out 1-for-38 Reverse Stock Split On September 19th, 2024
September 4th (Eastern Time) - $Cybin(CYBN.US)$ is about to implement a 1-for-38 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from September 19th, 2024.$
Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Cybin Inc. Shareholders Approve Key Decisions
Cybin Announces Results of Annual and Special Meeting of Shareholders and Share Consolidation